Company intelligence / Profile preview
Jilin Aodong Pharmaceutical Group Co., Ltd.
- Ownership
- Private
- Development stage
- Other
Overview
Jilin Aodong has a broad commercial portfolio with over 300 formulations including both traditional Chinese medicine and modern pharmaceuticals. Several key products are approved for use in China across a range of indications such as hepatitis B and diabetes mellitus. The company has reported strong financial growth with CNY ~3.2 billion revenue in the latest year and net profit of CNY ~400 million. Clinical trials have been conducted for bioequivalence studies and post-marketing safety.
- Therapeutic areas
- NephrologyPulmonologyEndocrinologyWomen's HealthOtherDermatologyRheumatologyGastroenterologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small molecule drugsherbal medicinesbiochemical medicinesplant chemical medicines
- Industry
- Biotech
Drug pipeline
7 assets6 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Jilin Aodong Pharmaceutical Group Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jilin Aodong Pharmaceutical Group Co., Ltd..